AR018304A2 - Acido clavulanico y composicion que lo contiene - Google Patents

Acido clavulanico y composicion que lo contiene

Info

Publication number
AR018304A2
AR018304A2 ARP990100913A ARP990100913A AR018304A2 AR 018304 A2 AR018304 A2 AR 018304A2 AR P990100913 A ARP990100913 A AR P990100913A AR P990100913 A ARP990100913 A AR P990100913A AR 018304 A2 AR018304 A2 AR 018304A2
Authority
AR
Argentina
Prior art keywords
clavulanic acid
composition containing
clavam
production
composition
Prior art date
Application number
ARP990100913A
Other languages
English (en)
Original Assignee
Smithkline Beecham Plc
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc, Univ Alberta filed Critical Smithkline Beecham Plc
Publication of AR018304A2 publication Critical patent/AR018304A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms

Abstract

Acido clavulánico que es obtenible por la fermentacion de un microorganismo que tiene facultades para la produccion de 5R-clavam y una produccionbaja o nula de 5S-clavam; y composicion que lo contiene.
ARP990100913A 1997-02-04 1999-03-04 Acido clavulanico y composicion que lo contiene AR018304A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9702218.0A GB9702218D0 (en) 1997-02-04 1997-02-04 Novel product

Publications (1)

Publication Number Publication Date
AR018304A2 true AR018304A2 (es) 2001-11-14

Family

ID=10807030

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP980100451A AR011100A1 (es) 1997-02-04 1998-02-02 Adn obtenible de s. clavuligerus, vector que comprende dicho adn, organismo hospedador, s. clavuligerus, procedimiento para mejorar la produccion de5r-clavam en un microorganismo adecuado, microorganismo que tiene las facultades para la produccion de 5r-clavam y una produccion baja o nula de 5s-
ARP990100913A AR018304A2 (es) 1997-02-04 1999-03-04 Acido clavulanico y composicion que lo contiene

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ARP980100451A AR011100A1 (es) 1997-02-04 1998-02-02 Adn obtenible de s. clavuligerus, vector que comprende dicho adn, organismo hospedador, s. clavuligerus, procedimiento para mejorar la produccion de5r-clavam en un microorganismo adecuado, microorganismo que tiene las facultades para la produccion de 5r-clavam y una produccion baja o nula de 5s-

Country Status (32)

Country Link
US (5) US6936458B1 (es)
EP (2) EP0970198B1 (es)
JP (2) JP4227199B2 (es)
KR (2) KR20050053794A (es)
CN (2) CN1192107C (es)
AP (1) AP1320A (es)
AR (2) AR011100A1 (es)
AT (1) ATE312926T1 (es)
AU (1) AU735782B2 (es)
BG (1) BG103704A (es)
BR (1) BR9807144A (es)
CA (1) CA2279207A1 (es)
DE (1) DE69832783T2 (es)
DZ (1) DZ2413A1 (es)
EA (1) EA003773B1 (es)
ES (1) ES2255149T3 (es)
GB (1) GB9702218D0 (es)
HU (1) HUP0001048A3 (es)
ID (1) ID22144A (es)
IL (1) IL131043A0 (es)
MA (1) MA24464A1 (es)
MY (1) MY140928A (es)
NO (1) NO993758L (es)
NZ (1) NZ336894A (es)
OA (1) OA11082A (es)
PL (1) PL334961A1 (es)
SK (1) SK105499A3 (es)
TR (1) TR199901862T2 (es)
TW (2) TW200307041A (es)
UY (2) UY24874A1 (es)
WO (1) WO1998033896A2 (es)
ZA (1) ZA98868B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001019959A1 (en) * 1999-09-16 2001-03-22 The Johns Hopkins University Improvement of clavulanic acid production
WO2001030977A2 (en) * 1999-10-22 2001-05-03 Smithkline Beecham P.L.C. 5r clavam producing microorganisms with deleted lat and cvm genes
GB0308696D0 (en) * 2003-04-15 2003-05-21 Glaxo Group Ltd New process
EP2589663A1 (en) 2011-11-04 2013-05-08 LEK Pharmaceuticals d.d. Process for production of clavulanic acid
CN107964522B (zh) * 2018-01-04 2020-12-08 上海交通大学 海洋链霉菌dut11及其抗补体活性应用
EP3994154A1 (en) 2019-07-05 2022-05-11 GlaxoSmithKline Intellectual Property (No.2) Limited Streptomyces clavuligerus

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110165A (en) * 1974-04-20 1978-08-29 Beecham Group Limited Process for the production of clavulanic acid
SE421796B (sv) * 1975-02-07 1982-02-01 Glaxo Lab Ltd Forfarande for rening av klavulansyra och dess salter
GB1585661A (en) 1976-06-08 1981-03-11 Glaxo Lab Ltd Clavam derivatives
JPS589679B2 (ja) 1977-02-24 1983-02-22 武田薬品工業株式会社 抗生物質の製造法
US4202819A (en) 1979-05-04 1980-05-13 Hoffman-La Roche Inc. 2-(3-Alanyl)clavam antibiotic
GB8521516D0 (en) * 1985-08-29 1985-10-02 Beecham Group Plc Compounds
GB9020683D0 (en) 1990-09-22 1990-11-07 Univ Strathclyde Isolation of dna
CA2108113C (en) * 1993-10-08 2006-12-05 Susan E. Jensen Dna sequence encoding enzymes of clavulanic acid biosynthesis

Also Published As

Publication number Publication date
US20030166175A1 (en) 2003-09-04
EP0970198A2 (en) 2000-01-12
HUP0001048A3 (en) 2001-09-28
AU6295398A (en) 1998-08-25
AP9901614A0 (en) 1999-09-30
WO1998033896A3 (en) 1998-11-19
UY25197A1 (es) 1998-11-27
CN1192107C (zh) 2005-03-09
TW589377B (en) 2004-06-01
EP1405913A2 (en) 2004-04-07
ZA98868B (en) 1999-08-03
UY24874A1 (es) 2001-07-31
WO1998033896A2 (en) 1998-08-06
JP2009022298A (ja) 2009-02-05
BG103704A (en) 2000-05-31
AU735782B2 (en) 2001-07-12
DZ2413A1 (fr) 2003-01-04
BR9807144A (pt) 2000-01-25
ES2255149T3 (es) 2006-06-16
GB9702218D0 (en) 1997-03-26
MA24464A1 (fr) 1998-10-01
PL334961A1 (en) 2000-03-27
MY140928A (en) 2010-02-12
EP0970198B1 (en) 2005-12-14
ATE312926T1 (de) 2005-12-15
KR100514964B1 (ko) 2005-09-15
NO993758D0 (no) 1999-08-03
OA11082A (en) 2003-03-13
HUP0001048A2 (hu) 2000-08-28
US6936458B1 (en) 2005-08-30
TR199901862T2 (xx) 2000-12-21
US20070298470A1 (en) 2007-12-27
ID22144A (id) 1999-09-09
TW200307041A (en) 2003-12-01
SK105499A3 (en) 2000-05-16
AP1320A (en) 2004-10-29
KR20050053794A (ko) 2005-06-08
KR20000070723A (ko) 2000-11-25
AR011100A1 (es) 2000-08-02
US20030022321A1 (en) 2003-01-30
CN1251612A (zh) 2000-04-26
CA2279207A1 (en) 1998-08-06
JP4227199B2 (ja) 2009-02-18
CN1696301A (zh) 2005-11-16
JP5042186B2 (ja) 2012-10-03
DE69832783T2 (de) 2006-07-20
EA199900718A1 (ru) 2000-02-28
EP1405913A3 (en) 2004-08-04
US20030124690A1 (en) 2003-07-03
US7344869B2 (en) 2008-03-18
IL131043A0 (en) 2001-01-28
JP2001511001A (ja) 2001-08-07
NZ336894A (en) 2001-08-31
NO993758L (no) 1999-08-03
DE69832783D1 (de) 2006-01-19
EA003773B1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
AU5736494A (en) Cyclic sulfone containing retroviral protease inhibitors
HN1997000110A (es) Derivados del acido arilsulfoonilamino hidroxamico
AU1984495A (en) Inhibition of hair growth
ES2196502T3 (es) Composicion y metodo para inhibir el desarrollo de microorganismos que incluye hipobromito sodico estabilizado e isotiazolonas.
ES2172027T3 (es) Reduccion del crecimiento del pelo.
FI952797A0 (fi) D-vitamiinianalogin uusi kiteinen muoto
AU5665194A (en) Sulfonylalkanoylamino hydroxyethylamino sulfamic acids useful as retroviral protease inhibitors
FI931336A0 (fi) Laekemedel som innehaoller polyhydroximetylenderivat, foerfarande foer deras framstaellning och bruk
AR018304A2 (es) Acido clavulanico y composicion que lo contiene
AU4765396A (en) Method of preparing retroviral protease inhibitor intermediates
DK0734380T3 (da) 4-Benzoylisoxazoler samt deres anvendelse som herbicider
ES2172002T3 (es) Composicion farmaceutica que contiene lornoxicam y una sal disodica del acido etilendiamintetraacetico.
ES2172589T3 (es) Tratamiento de la apoplegia asociada con la infiltracion de macrofagos.
ES540059A0 (es) Una composicion de conjugado de enzima estabilizado
DE69232661T2 (de) Enzymatischer prozess zur herstellung von cefonicid
ATE50595T1 (de) 2-oxocarbonsaeurereduktase, ihre herstellung und verwendung.
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
ES2144642T3 (es) Proceso de preparacion de la furosemida.
FI934468A (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytes mellanprodukter
ES2146607T3 (es) Mezcla proteolitica que contiene escarasa y metodo de aislar la misma.
ES2093984T3 (es) Procedimiento para la obtencion fermentativa de acido 2-hidroxifenilacetico.
AU1653100A (en) Use of diminazene-di-aceturate for treating malaria
ES2160249T3 (es) Mezclas fungicidas.
AR002458A1 (es) Preparado enzimatico que tiene actividad de cefalosporina haloperoxidasa y metodo para producir una cefalexina halogenada con dicho preparado.
ES2167568T3 (es) Procedimiento para la preparacion y recuperacion de acido 7-amino-desacetoxi-cefalosporanico.

Legal Events

Date Code Title Description
FB Suspension of granting procedure